Current therapy for rare factor deficiencies

Haemophilia

Volumn 7, Issue SUPPL. 1, 2001, Pages 16-22

  Di Paola, J ^a   Nugent, D ^a   Young, G ^a  

^a CHILDREN S HOSPITAL OF ORANGE COUNTY   (United States)

Author keywords

Clotting factor deficiencies; Factor V; Factor VII; Factor X; Factor XI; Factor XIII; Fibrinogen; Prothrombin

Indexed keywords

BEBULIN VH; BERIPLEX; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 13 CONCENTRATE; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 7 CONCENTRATE; BLOOD CLOTTING FACTOR 9; BLOOD CLOTTING FACTOR 9 COMPLEX; BLOOD CLOTTING FACTOR CONCENTRATE; FIBRINOGEN; FIBRINOGEN CLOTTAGEN; FIBRINOGEN HT; FRESH FROZEN PLASMA; HAEMOCOMPLETTAN; HEMOLEVEN; IMMUNOGLOBULIN; KONYNE 80; PROFILNINE SD; PROPLEX T; PROTHROMBIN; PROTHROMBIN COMPLEX; RECOMBINANT BLOOD CLOTTING FACTOR 7A; UNCLASSIFIED DRUG;

ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNE DISEASE; BLEEDING; BLEEDING DISORDER; BLEEDING TENDENCY; BLOOD; BLOOD CLOTTING FACTOR 10 DEFICIENCY; BLOOD CLOTTING FACTOR 11 DEFICIENCY; BLOOD CLOTTING FACTOR 13 DEFICIENCY; BLOOD CLOTTING FACTOR 5 DEFICIENCY; BLOOD CLOTTING FACTOR 7 DEFICIENCY; BLOOD CLOTTING FACTOR DEFICIENCY; CRYOPRECIPITATE; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; FIBRINOGEN DEFECT; GENETIC DISORDER; HEMOPHILIA A; HEMOPHILIA B; HUMAN; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; PROTHROMBIN DEFICIENCY; SIDE EFFECT; SYMPTOM; VON WILLEBRAND DISEASE;

EID: 0035129724     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2516.2001.00100.x     Document Type: Article

References (53)

1. Congenital afibrinogenemia
2. Successful treatment of two brothers with congenital afibrinogenemia for splenic rupture using heat-and solvent detergent-treated fibrinogen concentrates
3. Congenital afibringenemia and recurrent early abortion: A case report
4. Congenital afibrinogenemia and successful pregnancy
5. Acquired disorders of hemostasis
6. Necrose ischemique bilaterale dans un cas de grande hypofibrinogenemie congenitale
7. Congenital afibrinogenemia: Vascular changes and multiple thrombosis induced by fibrinogen infusions and contraceptive medication
8. Fatal pulmonary embolus in congenital fibrinopenia. Report of two cases
9. Congenital deficiencies and abnormalities of prothrombin
10. Hereditary deficiency of all vitamin K-dependent procoagulants and anticoagulants
11. Homozygosity for a novel missense mutation in the prothrombin gene causing a severe bleeding disorder
12. Severe factor V deficiency and neonatal intracranial hemorrhage: A case report
13. Bleeding symptoms in 27 Iranian patients with the combined deficiency of factor V and factor VIII
14. Molecular characterization of a type I quantitative factor V deficiency in a thrombosis patient that is 'Pseudohomozyous' for activated protein C resistance
15. Clinical significance of antibodies to bovine and human thrombin and factor V after surgical use of bovine thrombin
16. Development of antibodies to bovine and human factor V in two children after exposure to topical bovine thrombin
17. Inherited disorders of prothrombin conversion
18. Modulation of an acquired coagulation factor V inhibitor with intravenous immunoglobulin
19. Solvent/detergent-treated fresh frozen plasma: A virus-inactivated substitute for fresh frozen plasma
20. Inherited factor VII deficiency: Genetics and molecular pathology
21. Inherited disorders of prothrombin conversion
22. Thrombosis or myocardial infarction in congenital clotting factor abnormalities and chronic thrombocytopenias: A report of 21 patients and a review of 50 previously reported cases
23. Hereditary factor VII deficiency in pregnancy: Peripartum treatment with factor VII concentrate
24. Prophylaxis and therapy with factor VII concentrate (human) Immuno, vapor heated in patients with congenital factor VII deficiency: A summary of case reports
25. Recombinant factor VIIa for patients with inhibitors to factor VIII or IX or factor VII deficiency
26. Use of recombinant, activated factor VII in the treatment of congenital factor VII deficiencies
27. Congenital factor X deficiency: Spectrum of bleeding symptoms in 32 Iranian patients
28. Mechanism of factor X deficiency in systemic amyloidosis
29. Factor X deficiency during treatment of relapsed acute myeloid leukemia with amsacrine
30. Transient acquired factor X deficiency associated with pneumonia
31. Prevention of recurrent intracranial hemorrhage in a factor X deficient infant
32. Congenital coagulopathies and pregnancy: Report of four pregnancies in a factor X-deficient woman
33. Other coagulation factor deficiencies
34. Transient acquired factor X deficiency: Report of the use of activated clotting concentrate to control a life-threatening hemorrhage
35. Survival of transfused factor X in patients with Stuart disease
36. Factor XI deficiency
37. Definition of the bleeding tendency in factor XI deficient kindreds: A clinical and laboratory study
38. Factor XI deficiency
39. Factor XI deficiency in Ashkenazi Jews in Israel
40. The measurement of factor XI (plasma thromboplastin antecedent): Diagnosis and therapy of the congenital deficient state
41. Production and therapeutic use of a factor XI concentrate from plasma
42. Thrombogenic potential of factor XI concentrates
43. Activation of the coagulation cascade after infusion of a factor XI concentrate in congenitally deficient patients
44. In vivo coagulation activation following infusion of highly purified factor XI concentrate
45. Dental surgery in patients with severe factor XI deficiency without plasma replacement
46. Immunoelectrophoretic characterization of the cross-linking of fibrinogen and fibrin by factor XIIIa and tissue transglutaminase
47. Hereditary factor XIII deficiency: Report of four families and definition of the carrier state
48. Factor XIII
49. Intracranial hemorrhage in congenital deficiency of factor XIII
50. Successful pregnancy in a woman with congenital factor XIII deficiency treated with substitute therapy
51. A pasteurized concentrate of human plasma factor XIII for therapeutic use
52. Pharmacokinetics and tolerability of factor XIII concentrates prepared from human placenta or plasma: A crossover randomized study